|
private:xcellbiosciences
|
3880726
|
Dec 3rd, 2020 12:00AM
|
Xcell Biosciences
|
1.7K
|
19.00
|
Open
|
Biotechnology
|
Dec 3rd, 2020 03:30PM
|
Dec 3rd, 2020 03:30PM
|
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
|
Open
|
Primary Cell Culture, Cancer, Stem Cell, Immunotherapy, Immunooncology, Cell therapy, Immune cells, CAR-T
|
Open
|
455 Mission Bay Blvd S., Suite 145
|
San Francisco
|
California
|
US
|
94158
|
|
Xcell Biosciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:xcellbiosciences
|
3880726
|
Dec 2nd, 2020 12:00AM
|
Xcell Biosciences
|
1.7K
|
19.00
|
Open
|
Biotechnology
|
Dec 2nd, 2020 05:17PM
|
Dec 2nd, 2020 05:17PM
|
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
|
Open
|
Primary Cell Culture, Cancer, Stem Cell, Immunotherapy, Immunooncology, Cell therapy, Immune cells, CAR-T
|
Open
|
455 Mission Bay Blvd S., Suite 145
|
San Francisco
|
California
|
US
|
94158
|
|
Xcell Biosciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:xcellbiosciences
|
3880726
|
Dec 1st, 2020 12:00AM
|
Xcell Biosciences
|
1.7K
|
19.00
|
Open
|
Biotechnology
|
Dec 1st, 2020 03:54PM
|
Dec 1st, 2020 03:54PM
|
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
|
Open
|
Primary Cell Culture, Cancer, Stem Cell, Immunotherapy, Immunooncology, Cell therapy, Immune cells, CAR-T
|
Open
|
455 Mission Bay Blvd S., Suite 145
|
San Francisco
|
California
|
US
|
94158
|
|
Xcell Biosciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:xcellbiosciences
|
3880726
|
Nov 30th, 2020 12:00AM
|
Xcell Biosciences
|
1.7K
|
19.00
|
Open
|
Biotechnology
|
Nov 29th, 2020 09:49PM
|
Nov 30th, 2020 06:48PM
|
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
|
Open
|
Primary Cell Culture, Cancer, Stem Cell, Immunotherapy, Immunooncology, Cell therapy, Immune cells, CAR-T
|
Open
|
455 Mission Bay Blvd S., Suite 145
|
San Francisco
|
California
|
US
|
94158
|
|
Xcell Biosciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:xcellbiosciences
|
3880726
|
Nov 28th, 2020 12:00AM
|
Xcell Biosciences
|
1.7K
|
19.00
|
Open
|
Biotechnology
|
Nov 28th, 2020 05:22PM
|
Nov 28th, 2020 05:22PM
|
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
|
Open
|
Primary Cell Culture, Cancer, Stem Cell, Immunotherapy, Immunooncology, Cell therapy, Immune cells, CAR-T
|
Open
|
455 Mission Bay Blvd S., Suite 145
|
San Francisco
|
California
|
US
|
94158
|
|
Xcell Biosciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:xcellbiosciences
|
3880726
|
Nov 27th, 2020 12:00AM
|
Xcell Biosciences
|
1.7K
|
19.00
|
Open
|
Biotechnology
|
Nov 27th, 2020 01:49PM
|
Nov 27th, 2020 01:49PM
|
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
|
Open
|
Primary Cell Culture, Cancer, Stem Cell, Immunotherapy, Immunooncology, Cell therapy, Immune cells, CAR-T
|
Open
|
455 Mission Bay Blvd S., Suite 145
|
San Francisco
|
California
|
US
|
94158
|
|
Xcell Biosciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:xcellbiosciences
|
3880726
|
Nov 26th, 2020 12:00AM
|
Xcell Biosciences
|
1.7K
|
19.00
|
Open
|
Biotechnology
|
Nov 25th, 2020 08:58PM
|
Nov 25th, 2020 08:58PM
|
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
|
Open
|
Primary Cell Culture, Cancer, Stem Cell, Immunotherapy, Immunooncology, Cell therapy, Immune cells, CAR-T
|
Open
|
455 Mission Bay Blvd S., Suite 145
|
San Francisco
|
California
|
US
|
94158
|
|
Xcell Biosciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:xcellbiosciences
|
3880726
|
Nov 24th, 2020 12:00AM
|
Xcell Biosciences
|
1.7K
|
19.00
|
Open
|
Biotechnology
|
Nov 24th, 2020 04:32PM
|
Nov 24th, 2020 04:32PM
|
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
|
Open
|
Primary Cell Culture, Cancer, Stem Cell, Immunotherapy, Immunooncology, Cell therapy, Immune cells, CAR-T
|
Open
|
455 Mission Bay Blvd S., Suite 145
|
San Francisco
|
California
|
US
|
94158
|
|
Xcell Biosciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:xcellbiosciences
|
3880726
|
Nov 23rd, 2020 12:00AM
|
Xcell Biosciences
|
1.7K
|
19.00
|
Open
|
Biotechnology
|
Nov 23rd, 2020 06:21PM
|
Nov 23rd, 2020 06:21PM
|
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
|
Open
|
Primary Cell Culture, Cancer, Stem Cell, Immunotherapy, Immunooncology, Cell therapy, Immune cells, CAR-T
|
Open
|
455 Mission Bay Blvd S., Suite 145
|
San Francisco
|
California
|
US
|
94158
|
|
Xcell Biosciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:xcellbiosciences
|
3880726
|
Nov 22nd, 2020 12:00AM
|
Xcell Biosciences
|
1.7K
|
19.00
|
Open
|
Biotechnology
|
Nov 21st, 2020 07:05PM
|
Nov 22nd, 2020 05:17PM
|
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.
|
Open
|
Primary Cell Culture, Cancer, Stem Cell, Immunotherapy, Immunooncology, Cell therapy, Immune cells, CAR-T
|
Open
|
455 Mission Bay Blvd S., Suite 145
|
San Francisco
|
California
|
US
|
94158
|
|
Xcell Biosciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|